News - Legal, Rare diseases


Current filters:

LegalRare diseases

Popular Filters

News briefs: Novartis drops Ruvise MAA; B-MS settlement; Germany donates to Global Fund


The European Medicines Agency says it has been formally notified by Swiss drug major Novartis (NOVN:…

Anti-viralsBMS-986094Bristol-Myers SquibbFinancialLegalNovartisPharmaceuticalRare diseasesRegulationRuviseTropical diseases

News briefs on Sanofi, Novo Nordisk and GlaxoSmithKline/Amicus


Two US subsidiaries of French drug major Sanofi (Euronext: SAN) have agreed to pay $109 million to resolve…

Amicus TherapeuticsAmigalDiabetesFIAspFinancialGlaxoSmithKlineHyalganIDegLiraLegalNorth AmericaNovo NordiskPharmaceuticalRare diseasesResearchSanofi

Depomed sues FDA over orphan status exclusivity for Gralise


US drugmaker Depomed (Nasdaq: DEPO) says it has filed an action in federal district court for the District…

DepomedGraliseLegalNeurologicalNorth AmericaPharmaceuticalRare diseases

Pfizer's Elelyso approved in USA for Gaucher disease; Celebrex settlement


The US Food and Drug Administration yesterday approved Elelyso (taliglucerase alfa) for injection, an…

Anti-Arthritics/RheumaticsCelebrexElelysoLegalNorth AmericaPfizerPharmaceuticalProtalix BioTherapeuticsRare diseasesRegulationtaliglucerase

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top